DSM N.V.

DSM N.V. (AMS:DSM) Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in The Netherlands, today announces a major capacity expansion for its innovative picture glass ®claryl. Within a year after its launch, market demand for this innovative product has risen so quickly that DSM decided to build an additional oven at its manufacturing facility in Geleen, the Netherlands, increasing production capacity by 50%.

DSM N.V. (AMS:DSM) Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces that DSM Biomedical and Caliber Therapeutics, Inc. will partner on the development of a novel drug delivery balloon catheter that can be used to treat vascular diseases such as atherosclerosis. This cooperation is another step for DSM to leverage its competences in Materials Sciences into Life Sciences applications.

DSM N.V. (AMS:DSM) Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in The Netherlands, has successfully increased its outstanding EUR 300 million 4.00% bond due 2015 by EUR 200 million. The increase, triggered by interest of investors, has been placed to institutional investors across Europe.

DSM N.V. (AMS:DSM) Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces the inauguration of its new polymer plant in Jiangyin (Jiangsu province, China). The plant produces high viscosity grades of Akulon® polyamide 6 (PA6) aimed at the fast growing high end food packaging market in Asia. Construction of the plant, which was announced in September 2006, involved several tens of millions of USD.

DSM N.V. (AMS:DSM) Royal DSM N.V., the global Life Sciences and Materials Sciences Company headquartered in the Netherlands, today announces the closure of its citric acid manufacturing plant in Wuxi (China) by Q1 2009. The closure follows a request from the local government to relocate the plant from its current location as this location is needed for future urban developments. DSM will receive a compensation amount from the Wuxi government and does not expect to incur a book loss. A good social plan is being prepared for the several hundred people who will be affected by the closure.

DSM N.V. (AMS:DSM) DSM Venturing, the corporate venturing unit of Royal DSM N.V., today announces that it has acquired an equity stake of 29.3% in Provexis plc, an AIM listed company that develops and licenses ingredients for the functional food, medical food and dietary supplement market. The investment makes DSM the largest shareholder of Provexis.

DSM N.V. (AMS:DSM) DSM Engineering Plastics announces that it has reached an agreement on the acquisition of the polymerization assets of Diolen Industrial Fibers BV. These include the facilities for polyester polymer production in Emmen (Netherlands), which will now be integrated with DSM's polyester compounding facility in Emmen. As part of the acquisition, DSM will offer employment to 45 Diolen employees.

DSM N.V. (RDSMY) * DSM becomes official sponsor of Dutch swimmer Marleen Veldhuis * Broad range of innovations for Dutch Olympic Team * Innovations in the pipeline

DSM N.V. (RDSMY) Royal DSM N.V. has appointed Mrs A.M. (Margo) Vliegenthart as member of the Supervisory Board of DSM Nederland B.V. ("DSM Netherlands") with effect from 1 August 2008. Mrs Vliegenthart fills the vacancy caused by the untimely death of Mr M.A.M. (Thijs) Wöltgens earlier this year.

DSM N.V. (RDSMY) * Very strong Q2 result based on 17% organic sales growth. * Changing dynamics in vitamin business drive significantly higher profitability in Life Sciences. * Materials Sciences performing well against difficult economic background. * EBIT from continuing operations up 19% to EUR 276 million. * Earnings per share 34% higher. * Guidance raised: 2008 EBIT from continuing operations expected to be around EUR 970 million, with potential upside. * Execution of Vision 2010 strategy fully on track.